AJR Am J Roentgenol
- GASTOUNIOTI A, Kontos D
Artificial Intelligence in Breast Imaging Daily Clinical Practice:
Point-Reshaping Breast Cancer Screening.
AJR Am J Roentgenol. 2024 Mar 27. doi: 10.2214/AJR.24.31174.
Am J Clin Oncol
- NICHOLSON G, Carlson KB, Hernandez RK, Schenfeld J, et al
Treatment Patterns of Bone-targeting Agents Among Solid Tumor Patients With Bone
Metastases: An Analysis of Electronic Health Record Data in the United States
From 2014 to 2018.
Am J Clin Oncol. 2024;47:177-184.
Am J Pathol
- LINSCOTT M, Ren JR, Gestl S, Gunther EJ, et al
Different oncogenes and reproductive histories shape the progression of distinct
premalignant clones in multistage mouse breast cancer models.
Am J Pathol. 2024 Mar 25:S0002-9440(24)00112.
Ann Surg
- GOEL N, Hernandez AE, Antoni MH, Kesmodel S, et al
ZIP Code to Genomic Code: Neighborhood Disadvantage, Aggressive Breast Cancer
Biology, and Breast Cancer Outcomes.
Ann Surg. 2024 Mar 28. doi: 10.1097/SLA.0000000000006283.
Ann Surg Oncol
- SCODARI BT, Schaefer AP, Kapadia NS, Brooks GA, et al
The Association Between Oncology Outreach and Timely Treatment for Rural Patients
with Breast Cancer: A Claims-Based Approach.
Ann Surg Oncol. 2024 Mar 27. doi: 10.1245/s10434-024-15195.
- NIJVELDT JJ, Rajan KK, Boersma K, Noorda EM, et al
Implementation of the Targeted Axillary Dissection Procedure in Clinically
Node-Positive Breast Cancer: A Retrospective Analysis.
Ann Surg Oncol. 2024 Mar 24. doi: 10.1245/s10434-024-15182.
Anticancer Res
- SATO M, Han Q, Mori R, Mizuta K, et al
Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic
Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer
Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant
Methion
Anticancer Res. 2024;44:1499-1504.
- CIMPEAN AM, Comsa S, Sturza A, Barb AC, et al
Validation of Human Bone Marrow-derived Mesenchymal Stem Cells and MCF-7 Breast
Cancer Cells Co-culture Using a 3D Perfused Biomimetic Microfluidic Platform.
Anticancer Res. 2024;44:1441-1453.
- KITSUYA N, Matsuoka M, Onodera T, Yokota I, et al
Surgical Resection of Primary Tumor for Bone Metastatic Breast Cancer Patients at
Initial Presentation.
Anticancer Res. 2024;44:1591-1601.
- RADES D, Kristiansen C, Timke C, Duma MN, et al
Clinically Significant Dermatitis During Adjuvant Radiotherapy for Invasive
Breast Cancer.
Anticancer Res. 2024;44:1525-1531.
- ARDAVANIS-LOUKERIS G, Kokkali S, Perdikari K, Karatrasoglou E, et al
A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone
Receptor-positive, HER2-negative Advanced Breast Cancer.
Anticancer Res. 2024;44:1559-1565.
BMC Cancer
- HUANG W, Wang C, Shen Y, Chen Q, et al
Correction: A real-world study of the effectiveness and safety of apatinib-based
regimens in metastatic triple-negative breast cancer.
BMC Cancer. 2024;24:378.
- CHEHELGERDI M, Khorramian-Ghahfarokhi M, Dehkordi FB, Chehelgerdi M, et al
Comment on "A novel super-enhancer-related gene signature predicts prognosis and
immune microenvironment for breast cancer".
BMC Cancer. 2024;24:377.
- ESMAT E, Haidary AM, Saadaat R, Rizvi SN, et al
Association of hormone receptors and human epidermal growth factor receptor-2/neu
expressions with clinicopathologic factors of breast carcinoma: a cross-sectional
study in a tertiary care hospital, Kabul, Afghanistan.
BMC Cancer. 2024;24:388.
- ZAHEDI H, Alizadeh-Dibazari Z, Mirghafourvand M, Sahebihagh MH, et al
The effectiveness of couple-based interventions on the marital outcomes of women
with genital and breast cancer and their partners: a systematic review and
meta-analysis.
BMC Cancer. 2024;24:391.
Br J Cancer
- LIU X, Cheng X, Xie F, Li K, et al
Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and
tumour immunity in first-line HER2-positive metastatic breast cancer.
Br J Cancer. 2024 Mar 22. doi: 10.1038/s41416-024-02610.
Breast Cancer Res
- QIAN J, Ma Y, Tahaney WM, Moyer CL, et al
Correction: The novel phosphatase NUDT5 is a critical regulator of
triple-negative breast cancer growth.
Breast Cancer Res. 2024;26:53.
- MULLOOLY M, Fan S, Pfeiffer RM, Bowles EA, et al
Temporal changes in mammographic breast density and breast cancer risk among
women with benign breast disease.
Breast Cancer Res. 2024;26:52.
Breast Cancer Res Treat
- HARDY-ABELOOS C, Xiao J, Oh C, Barbee D, et al
Effectiveness and toxicity of five-fraction prone accelerated partial breast
irradiation.
Breast Cancer Res Treat. 2024;204:485-495.
- VAN HEMERT A, van Loevezijn AA, Bosman A, Vlahu CA, et al
Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma:
surgical and oncologic outcome.
Breast Cancer Res Treat. 2024;204:497-507.
- WANG H, Yee D, Potter D, Jewett P, et al
Impact of body mass index on pathological response after neoadjuvant
chemotherapy: results from the I-SPY 2 trial.
Breast Cancer Res Treat. 2024;204:589-597.
- FLETCHER KA, Alkurashi MH, Lindsay AJ
Endosomal recycling inhibitors downregulate estrogen receptor-alpha and synergise
with endocrine therapies.
Breast Cancer Res Treat. 2024;204:631-642.
- WALSH EA, Post K, Massad K, Horick N, et al
Identification of patient subgroups who benefit from a behavioral intervention to
improve adjuvant endocrine therapy adherence: a randomized-controlled trial.
Breast Cancer Res Treat. 2024;204:547-559.
- COLLIN LJ, Jones J, Nash R, Switchenko JM, et al
Racial disparities in initiation of chemotherapy among breast cancer patients
with discretionary treatment indication in the state of Georgia.
Breast Cancer Res Treat. 2024 Mar 22. doi: 10.1007/s10549-024-07279.
- DOUBBLESTEIN D, Koehler L, Anderson E, Scheiman N, et al
Development of a core set of outcome measures to be applied toward breast
cancer-related lymphedema core outcome domains.
Breast Cancer Res Treat. 2024 Mar 22. doi: 10.1007/s10549-024-07298.
- GODINEZ PAREDES JM, Rodriguez I, Ren M, Orozco A, et al
Germline pathogenic variants associated with triple-negative breast cancer in US
Hispanic and Guatemalan women using hospital and community-based recruitment
strategies.
Breast Cancer Res Treat. 2024 Mar 23. doi: 10.1007/s10549-024-07300.
- KAPLAN HG, Dowdell AK, Berry AB, Shimol RB, et al
Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast
cancer.
Breast Cancer Res Treat. 2024 Mar 24. doi: 10.1007/s10549-024-07270.
- TENG YT, Wang YA, Dong YH, Liu JJ, et al
Five-year survival prognosis of young, middle-aged, and elderly adult female
invasive breast cancer patients by clinical and lifestyle characteristics.
Breast Cancer Res Treat. 2024 Mar 25. doi: 10.1007/s10549-024-07280.
- JUNG JJ, Cheun JH, Kim HK, Lee HB, et al
Comparison of long-term oncologic outcomes of central lumpectomy and conventional
breast-conserving surgery for invasive breast cancer: propensity score matching
analysis.
Breast Cancer Res Treat. 2024 Mar 25. doi: 10.1007/s10549-024-07297.
- GULIYEV M, Sen GA, Gulturk I, Majidova N, et al
The effects of low HER2 expression on survival in patients with metastatic breast
cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study.
Breast Cancer Res Treat. 2024 Mar 25. doi: 10.1007/s10549-024-07291.
Cancer
- WANG X, O'Regan RM
Breast cancer therapy in China: Introducing the Special Collection.
Cancer. 2024 Mar 25. doi: 10.1002/cncr.35288.
Clin Breast Cancer
- DAVEY MG, Tormey S
Implications of Highly Penetrant Genetic Variants on Breast Surgery.
Clin Breast Cancer. 2024;24:180-183.
- NAG S, Berlin L, Hunter K, Bonawitz SC, et al
Effects of Neoadjuvant Chemotherapy on Autologous and Implant-Based Breast
Reconstruction: A Systematic Review and Meta-Analysis of the Literature.
Clin Breast Cancer. 2024;24:184-190.
- CHI Y, Hirachan S, Zhou Y, Bhandari A, et al
Exploring the Oncogenic Potential of TIMM8A: A Crucial Factor in Breast Cancer
Tumorigenesis.
Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00049.
- GRZYWACZ VP, Lehrberg AV, Quinn TJ, Zureick AH, et al
Breast Conserving Therapy for Patients With Prior Cosmetic Implant-Based Breast
Augmentation: Outcomes and Comparison Against a Matched Cohort.
Clin Breast Cancer. 2024;24:227-236.
- DURAN C, Ward RC, Dibble EH
(18)F-FES PET/CT for Post-Cryoablation Evaluation of Breast Cancer.
Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00043.
- LI G, Huang Z, Luo H, Tian H, et al
Photoacoustic Imaging Radiomics to Identify Breast Cancer in BI-RADS 4 or 5
Lesions.
Clin Breast Cancer. 2024 Feb 29:S1526-8209(24)00055.
- STAFFORD L, Sinclair M, Butow P, Hughes J, et al
Quality of Life Outcomes Associated With Optimization of Treatment by Omitting
Radiotherapy in Early Breast Cancer.
Clin Breast Cancer. 2024 Mar 6:S1526-8209(24)00062.
- MA S, Liu Y, Gao P, Ma R, et al
Independent Validation of the BRENDA-Score Breast Cancer Prognosis Prediction
Tool In Chinese Patients.
Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00058.
- SONDERGAARD SR, Stie M, Bechmann T, Offersen BV, et al
Through Clinicians Eyes: Use of an In-consultation Patient Decision Aid in
Radiation Treatment for Early Breast Cancer. A Qualitative Study.
Clin Breast Cancer. 2024 Feb 21:S1526-8209(24)00045.
- DAI L, Yan W, Ren X, Liu D, et al
Construction and Validation of a Nomogram Predicting the Overall Survival Benefit
of Unilateral Breast Cancer Patients Undergoing Contralateral Prophylactic
Mastectomy.
Clin Breast Cancer. 2024 Feb 7:S1526-8209(24)00039.
- XU D, Wang K, Lin C, Li D, et al
Can We Do Breast-Conserving Surgery Without Intraoperative Frozen Section of
Margin?
Clin Breast Cancer. 2024;24:191-198.
- SFARAD HK, Allweis TM
Postoperative Complications Following Lumpectomy With Intraoperative X-Ray
Radiation Therapy: A Retrospective Comparative Study.
Clin Breast Cancer. 2024;24:237-242.
Clin Exp Metastasis
- LEDUC S, Nguyen HL, Richard F, Zels G, et al
Transcriptomic characterization of the histopathological growth patterns in
breast cancer liver metastases.
Clin Exp Metastasis. 2024 Mar 29. doi: 10.1007/s10585-024-10279.
Eur J Surg Oncol
- TASOULIS MK, Muktar S, Smith I, Roche N, et al
Omission of breast surgery in selected breast cancer patients with excellent
response to neoadjuvant systemic therapy.
Eur J Surg Oncol. 2024;50:108277.
Int J Cancer
- WANG T, Chai B, Chen WY, Holmes MD, et al
Metformin and other anti-diabetic medication use and breast cancer incidence in
the Nurses' Health Studies.
Int J Cancer. 2024 Mar 22. doi: 10.1002/ijc.34917.
- SONGISO M, Nunez O, Cabanes A, Mutale M, et al
Three-year survival of breast cancer patients attending a one-stop breast care
clinic nested within a primary care health facility in sub-Saharan Africa-Zambia.
Int J Cancer. 2024 Mar 25. doi: 10.1002/ijc.34920.
- WU H, Wang W, Zhang Y, Chen Y, et al
Establishment of patient-derived organoids for guiding personalized therapies in
breast cancer patients.
Int J Cancer. 2024 Mar 27. doi: 10.1002/ijc.34931.
J Clin Oncol
- MARTIN M, Lim E, Chavez-MacGregor M, Bardia A, et al
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated
Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast
Cancer Study.
J Clin Oncol. 2024 Mar 27:JCO2301500. doi: 10.1200/JCO.23.01500.
J Nucl Med
- ALTENA R, Buren SA, Blomgren A, Karlsson E, et al
Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast
Cancer with [(68)Ga]Ga-ABY-025: Results from a Pilot Study.
J Nucl Med. 2024 Mar 28:jnumed.123.266847. doi: 10.2967/jnumed.123.266847.
J Surg Oncol
- VALENTE S, Roesch E
Breast cancer survivorship.
J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27627.
Lancet Oncol
- LAYMAN RM, Han HS, Rugo HS, Stringer-Reasor EM, et al
Gedatolisib in combination with palbociclib and endocrine therapy in women with
hormone receptor-positive, HER2-negative advanced breast cancer: results from the
dose expansion groups of an open-label, phase 1b study.
Lancet Oncol. 2024;25:474-487.
- BROWNE IM, Andre F, Chandarlapaty S, Carey LA, et al
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive
breast cancer.
Lancet Oncol. 2024;25:e139-e151.
Nat Rev Clin Oncol
- SIDAWAY P
KN046 shows tolerability and activity in TNBC.
Nat Rev Clin Oncol. 2024;21:251.
NPJ Breast Cancer
- KULKARNI AA, Jain A, Jewett PI, Desai N, et al
Association of antibiotic exposure with residual cancer burden in HER2-negative
early stage breast cancer.
NPJ Breast Cancer. 2024;10:24.
PLoS One
- NIU X, Wang J, Liu J, Yu Q, et al
17beta-Estradiol promotes metastasis in triple-negative breast cancer through the
Calpain/YAP/beta-catenin signaling axis.
PLoS One. 2024;19:e0298184.
- EBRAHIMPOUR-KOUJAN S, Benisi-Kohansal S, Azadbakht L, Fallah M, et al
Adherence to HEI-2010 and odds of breast cancer according to the menopause
status: Evidence from Middle Eastern Country.
PLoS One. 2024;19:e0300986.
- DEMEKE T, Hailemariam D, Santos P, Seife E, et al
Willingness and ability to pay for breast cancer treatment among patients from
Addis Ababa, Ethiopia: A cross-sectional study.
PLoS One. 2024;19:e0300631.
- RAGHURAM GV, Pal K, Sriram G, Khan A, et al
Correction: Therapeutic interventions on human breast cancer xenografts promote
systemic dissemination of oncogenes.
PLoS One. 2024;19:e0301650.
-
Retraction: Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal
Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC)
Subpopulation Enriched from Breast Cancer Cells.
PLoS One. 2024;19:e0300804.
Radiology
- KUHL CK
Abbreviated Breast MRI: State of the Art.
Radiology. 2024;310:e221822.
- ZHOU LQ, Wu XL, Huang SY, Wu GG, et al
Erratum for: Lymph Node Metastasis Prediction from Primary Breast Cancer US
Images Using Deep Learning.
Radiology. 2024;310:e249009.
- CHEN Y, Taib AG, Darker IT, James JJ, et al
Erratum for: Performance of a Breast Cancer Detection AI Algorithm Using the
Personal Performance in Mammographic Screening Scheme.
Radiology. 2024;310:e249007.
Radiother Oncol
- FRANCESCHINI D, Franzese C, Comito T, Ilieva MB, et al
Definitive results of a prospective non-randomized phase 2 study on stereotactic
body radiation therapy (sbrt) for medically inoperable lung and liver
oligometastases from breast cancer.
Radiother Oncol. 2024;195:110240.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016